Guizhou Salvage Pharmaceutical Co Ltd
SSE:600227
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guizhou Salvage Pharmaceutical Co Ltd
Total Receivables
Guizhou Salvage Pharmaceutical Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guizhou Salvage Pharmaceutical Co Ltd
SSE:600227
|
Total Receivables
¥38.9m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-25%
|
|
|
Yunnan Yuntianhua Co Ltd
SSE:600096
|
Total Receivables
¥2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
|
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
Total Receivables
¥4.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
43%
|
CAGR 10-Years
21%
|
|
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
Total Receivables
¥2.3B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Zangge Mining Co Ltd
SZSE:000408
|
Total Receivables
¥131.4m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-10%
|
|
|
Asia Potash International Investment Guangzhou Co Ltd
SZSE:000893
|
Total Receivables
¥51.2m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-13%
|
|
Guizhou Salvage Pharmaceutical Co Ltd
Glance View
Guizhou Salvage Pharmaceutical Co., Ltd. engages in the operation of chemical fertilizer and pharmaceutical business. The company is headquartered in Guiyang, Guizhou and currently employs 1,227 full-time employees. The company went IPO on 2000-02-21. The firm is engaged in the production and sales of urea and methyl alcohol. The firm is also engaged in the production and sales of drugs, medical devices and health products. Its drugs are applied in the treatment of diabetes and others. The firm also engages in the distribution of pharmaceuticals. The firm mainly operates its businesses in Guizhou, Sichuan, Chongqing, Guangxi, Gunagdong, Hunan and other regions.
See Also
What is Guizhou Salvage Pharmaceutical Co Ltd's Total Receivables?
Total Receivables
38.9m
CNY
Based on the financial report for Sep 30, 2025, Guizhou Salvage Pharmaceutical Co Ltd's Total Receivables amounts to 38.9m CNY.
What is Guizhou Salvage Pharmaceutical Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
-25%
Over the last year, the Total Receivables growth was -74%. The average annual Total Receivables growth rates for Guizhou Salvage Pharmaceutical Co Ltd have been -61% over the past three years , -46% over the past five years , and -25% over the past ten years .
